Home
Storia in 1 fonti
Why Is ADC Therapeutics Stock Falling Thursday? - ADC Therapeutics (NYSE:ADCT)
ADC Therapeutics stock plunges premarket as LOTIS-3 trial shows elevated serious, Grade 5 adverse events despite meeting its primary endpoint.
Raccontata da
benzinga.com
Timeline cronologica
- ·
Why Is ADC Therapeutics Stock Falling Thursday? - ADC Therapeutics (NYSE:ADCT)
ADC Therapeutics stock plunges premarket as LOTIS-3 trial shows elevated serious, Grade 5 adverse events despite meeting its primary endpoint.
- ·
Why Is ADC Therapeutics Stock Falling On Friday? - ADC Therapeutics (NYSE:ADCT)
Discover why ADC Therapeutics (NYSE:ADCT) stock is tumbling on Friday as a prominent Wall Street analyst slashes targets due to serious trial safety signals.